Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes
Authors:
- 1 January 2018
- journal article
- research article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 65 (4) , 461-467
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 34 references indexed in Scilit:
- Long-Term Effect of Weight Loss on Obstructive Sleep Apnea Severity in Obese Patients with Type 2 DiabetesSLEEP, 2013
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on MetforminThe Journal of Clinical Endocrinology & Metabolism, 2012
- Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up studyBMJ, 2011
- Non-CPAP therapies in obstructive sleep apnoeaEuropean Respiratory Journal, 2011
- Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary reportJournal of Human Hypertension, 2009
- A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesThe Sleep AHEAD StudyEffect of Weight Loss on Obstructive Sleep ApneaArchives of internal medicine (1960), 2009
- Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesDiabetes Care, 2009
- Abdominal Fat and Sleep ApneaDiabetes Care, 2008
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- CLINICAL REVIEW ARTICLE: Epidemiology of sleep-related obstructive breathingSleep Medicine Reviews, 2000